Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis.

Abstract

Worldwide, tuberculosis (TB) remains the most frequent and important infectious disease causing morbidity and death. One-third of the world's population is infected with Mycobacterium tuberculosis (MTB), the etiologic agent of TB. Because of the global health problems of TB, the development of potent new anti-TB drugs without cross-resistance with known… (More)

Topics

Cite this paper

@article{Chen2007AptamerFW, title={Aptamer from whole-bacterium SELEX as new therapeutic reagent against virulent Mycobacterium tuberculosis.}, author={Fan Chen and Jing Zhou and Fengling Luo and Al-Bayati Mohammed and Xiaolian Zhang}, journal={Biochemical and biophysical research communications}, year={2007}, volume={357 3}, pages={743-8} }